REG - NetScientific PLC - PDS Biotechnology proposed offering
RNS Number : 6657CNetScientific PLC11 February 2020NetScientific plc
("NetScientific" or the "Company")
PDS Biotechnology proposed offering
NetScientific plc ("NetScientific", AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces that its portfolio company PDS Biotechnology Corporation ("PDS") (Nasdaq:PDSB) today made a further announcement concerning its proposed offering to raise approximately US$12 million (c.£9.3 million).
PDS mentioned in today's announcement that, in connection with NetScientific's expression of interest to subscribe in its offering, upon consummation of the offering it will appoint a designee of NetScientific to its board of directors.
NertScientific is considering investing £0.5 million in the offering.
A further announcement will be made as soon as appropriate.
For more information, please contact:
NetScientific Tel: 020 3514 1800
Ian Postlethwaite, CEO and
CFO
Tel: 020 7220 1666
WH Ireland (NOMAD and Broker)
Chris Fielding / Darshan Patel
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDMSCKKDBBQBKDBBD
Recent news on Netscientific
See all newsREG - NetScientific PLC - ProAxsis secures c.£1.8mn investment
AnnouncementREG - NetScientific PLC - PDS Strategy Update and 2023 Financial Results
AnnouncementREG - NetScientific PLC - Business Update
AnnouncementREG - NetScientific PLC - Exercise of Options and Issue of Shares
AnnouncementREG - NetScientific PLC - Glycotest secures $1 million investment
Announcement